FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076448614> ?p ?o ?g. }

• W2076448614 endingPage "472" @default.
• W2076448614 startingPage "465" @default.
• W2076448614 abstract "Opioid peptides are present in human cerebrospinal fluid (CSF), and their levels are reported to change in some pathologic conditions. However, less is known about their degradation in CSF. In the present study, human CSF was found to contain aminopeptidase activity which hydrolyzed alanyl-, leucyl- and arginyl-naphthylamides in a ratio of 100 : 28 : 27. Twelve CSF samples hydrolyzed alanyl-2-naphthylamide and degraded Met5-enkephalin (N-terminal hydrolysis) at rates of 188 ± 38 and 420 ± 79 pmol/min/mL respectively. Further, the distribution of alanyl-naphthylamidase activity in individual samples (39–437 pmol/min/mL) was closely correlated with that of Met5 -enkephalin degradation (37–833 pmol/min/mL). Both alanyl-naphthylamidase and enkephalin degradation were optimal at pH 7.0 to 7.5 and were inhibited by the aminopeptidase inhibitors amastatin (ic50 = 20 nM), bestatin (4–7 μM) and puromycin (30–35 μM). Conversely, degradation was unaffected by inhibitors of neutral endopeptidase (phosphoramidon), carboxypeptidase N (MERGETPA) or angiotensin converting enzyme (captopril). The Km of Met5 enkephalin for the CSF aminopeptidase activity was 201 ± 19 μM (N = 4). Rates of hydrolysis of the Tyr1-Gly2 bond of larger opioid peptides decreased with increasing peptide length. Pooled, concentrated CSF hydrolyzed Leu5-enkephalin, dynorphin A fragments [1–7], [1–10] and [1–13] and dynorphin A at rates of 2.05 ± 0.27, 1.76 ±0.18, 0.94 ± 0.06, 0.55 ± 0.14 and 0.16 ± 0.03 nmol/min/mL respectively. When analyzed by rocket-immunoelectrophoresis against antisera to aminopeptidase M (EC 3.4.11.2), the concentrated CSF formed an immunoprecipitate which could be stained histochemically for alanyl-naphthylamidase activity. These data are consistent with a significant role for aminopeptidase M activity in the degradation of low molecular weight opioid peptides in human CSF." @default.
• W2076448614 created "2016-06-24" @default.
• W2076448614 creator A5012210618 @default.
• W2076448614 creator A5016462986 @default.
• W2076448614 creator A5049361872 @default.
• W2076448614 creator A5070003739 @default.
• W2076448614 date "1990-08-01" @default.
• W2076448614 modified "2023-10-03" @default.
• W2076448614 title "N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid" @default.
• W2076448614 cites W1449076744 @default.
• W2076448614 cites W1966028304 @default.
• W2076448614 cites W1971903700 @default.
• W2076448614 cites W1972321263 @default.
• W2076448614 cites W1976936635 @default.
• W2076448614 cites W1980623360 @default.
• W2076448614 cites W1983585961 @default.
• W2076448614 cites W1989479135 @default.
• W2076448614 cites W1990262681 @default.
• W2076448614 cites W1990401947 @default.
• W2076448614 cites W1992570030 @default.
• W2076448614 cites W1998256759 @default.
• W2076448614 cites W1999371904 @default.
• W2076448614 cites W2001612736 @default.
• W2076448614 cites W2002020746 @default.
• W2076448614 cites W2004266307 @default.
• W2076448614 cites W2007270109 @default.
• W2076448614 cites W2007626911 @default.
• W2076448614 cites W2008730065 @default.
• W2076448614 cites W2009715750 @default.
• W2076448614 cites W2016283579 @default.
• W2076448614 cites W2032527635 @default.
• W2076448614 cites W2036416113 @default.
• W2076448614 cites W2042769942 @default.
• W2076448614 cites W2046622344 @default.
• W2076448614 cites W2056865511 @default.
• W2076448614 cites W2057487553 @default.
• W2076448614 cites W2067971459 @default.
• W2076448614 cites W2082102151 @default.
• W2076448614 cites W2085461283 @default.
• W2076448614 cites W2093308414 @default.
• W2076448614 cites W2093944079 @default.
• W2076448614 cites W21076497 @default.
• W2076448614 cites W2460277341 @default.
• W2076448614 doi "https://doi.org/10.1016/0006-2952(90)90544-u" @default.
• W2076448614 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1974424" @default.
• W2076448614 hasPublicationYear "1990" @default.
• W2076448614 type Work @default.
• W2076448614 sameAs 2076448614 @default.
• W2076448614 citedByCount "24" @default.
• W2076448614 countsByYear W20764486142016 @default.
• W2076448614 countsByYear W20764486142023 @default.
• W2076448614 crossrefType "journal-article" @default.
• W2076448614 hasAuthorship W2076448614A5012210618 @default.
• W2076448614 hasAuthorship W2076448614A5016462986 @default.
• W2076448614 hasAuthorship W2076448614A5049361872 @default.
• W2076448614 hasAuthorship W2076448614A5070003739 @default.
• W2076448614 hasConcept C104826730 @default.
• W2076448614 hasConcept C108477463 @default.
• W2076448614 hasConcept C126322002 @default.
• W2076448614 hasConcept C134018914 @default.
• W2076448614 hasConcept C151077648 @default.
• W2076448614 hasConcept C170493617 @default.
• W2076448614 hasConcept C181199279 @default.
• W2076448614 hasConcept C185592680 @default.
• W2076448614 hasConcept C2776580952 @default.
• W2076448614 hasConcept C2777803847 @default.
• W2076448614 hasConcept C2780268870 @default.
• W2076448614 hasConcept C2780919550 @default.
• W2076448614 hasConcept C2780985610 @default.
• W2076448614 hasConcept C2781063702 @default.
• W2076448614 hasConcept C515207424 @default.
• W2076448614 hasConcept C55493867 @default.
• W2076448614 hasConcept C71924100 @default.
• W2076448614 hasConcept C86803240 @default.
• W2076448614 hasConcept C88016717 @default.
• W2076448614 hasConcept C94412978 @default.
• W2076448614 hasConceptScore W2076448614C104826730 @default.
• W2076448614 hasConceptScore W2076448614C108477463 @default.
• W2076448614 hasConceptScore W2076448614C126322002 @default.
• W2076448614 hasConceptScore W2076448614C134018914 @default.
• W2076448614 hasConceptScore W2076448614C151077648 @default.
• W2076448614 hasConceptScore W2076448614C170493617 @default.
• W2076448614 hasConceptScore W2076448614C181199279 @default.
• W2076448614 hasConceptScore W2076448614C185592680 @default.
• W2076448614 hasConceptScore W2076448614C2776580952 @default.
• W2076448614 hasConceptScore W2076448614C2777803847 @default.
• W2076448614 hasConceptScore W2076448614C2780268870 @default.
• W2076448614 hasConceptScore W2076448614C2780919550 @default.
• W2076448614 hasConceptScore W2076448614C2780985610 @default.
• W2076448614 hasConceptScore W2076448614C2781063702 @default.
• W2076448614 hasConceptScore W2076448614C515207424 @default.
• W2076448614 hasConceptScore W2076448614C55493867 @default.
• W2076448614 hasConceptScore W2076448614C71924100 @default.
• W2076448614 hasConceptScore W2076448614C86803240 @default.
• W2076448614 hasConceptScore W2076448614C88016717 @default.
• W2076448614 hasConceptScore W2076448614C94412978 @default.
• W2076448614 hasIssue "3" @default.
• W2076448614 hasLocation W20764486141 @default.

• next